Comprehensive review of Chromatographic, Hyphenated, and Spectrophotometric methods for the determination of Loxoprofen Sodium

Authors

  • Sonika S. Doifode Department of Pharmaceutical Chemistry, KLE’s College of Pharmacy; Rajiv Gandhi University of Health Sciences image/svg+xml https://orcid.org/0009-0005-8105-9569
  • Rupesh Kulkarni Department of Pharmaceutical Chemistry

DOI:

https://doi.org/10.22456/dar.v10i1.154322

Keywords:

Loxoprofen sodium, Chromatographic methods, UV spectrophotometry, Method development, Stability-indicating analysis, RP-HPLC, HPTLC, UHPLC

Abstract

Loxoprofen sodium, a propionic acid derivative and non-steroidal anti-inflammatory drug (NSAID), is widely prescribed for the management of pain, inflammation, and musculoskeletal disorders. As its therapeutic application expands, robust and precise analytical methods are essential to ensure the quality, safety, and efficacy of loxoprofen sodium in bulk drug substances, pharmaceutical formulations, and biological matrices. In recent years, significant progress has been made in the development and validation of analytical approaches, including UV spectrophotometry, RP-HPLC, HPTLC, and advanced UHPLC techniques. Optimization of chromatographic parameters, such as mobile phase composition, column selection, and detection wavelength, has enhanced sensitivity, resolution, and reproducibility. Method validation, in line with ICH guidelines, routinely evaluates accuracy, precision, linearity, specificity, and robustness to confirm reliability. Stability-indicating methods are particularly important for assessing degradation under stress conditions, providing insight into drug stability and shelf-life. Current analytical trends emphasize green and quality-by-design (QbD) approaches, supporting eco-friendly and efficient method development. Collectively, these analytical advancements establish a comprehensive framework for the routine quality control and research of loxoprofen sodium, reinforcing its clinical relevance and regulatory compliance.

Downloads

Download data is not yet available.

References

Han H, Ro DH, Han HS, Won S. Overall compilation of adverse effects of non-steroidal anti-inflammatory drugs: a hypothesis-free systematic investigation using a nationwide cohort study. Frontiers in Pharmacology. 2025 Apr 2; 16:1539328. DOI: https://doi.org/10.3389/fphar.2025.1539328

Maurice-Szamburski A, Quemeneur C, Rozier R, Cuvillon P, Ecoffey C. Intravenously administered nonsteroidal anti-inflammatory drugs in clinical practice: a narrative review. Pharmacy. 2025 Feb 4;13(1):18. DOI: https://doi.org/10.3390/pharmacy13010018

Lei Y, Liu Z, Jin X, Gao G, Luo S, Gao X, Liu Q, Yang P, Tian R. Efficacy and safety of loxoprofen sodium cataplasms in the treatment of osteoarthritis: A randomized, multicenter study. Biomedical Reports. 2025 Feb 4;22(4):57. DOI: https://doi.org/10.3892/br.2025.1935

Liu M, Yang H, Wang Y, Fu W, Dong C, Ye A, Zou Y, Sun S, Han D, Zhang H, Qiu Y. Preparation of combined colchicine with loxoprofen sodium loaded in dissolvable microneedles and its anti-gouty arthritis effect. Journal of Drug Delivery Science and Technology. 2025 Feb 1;104:106471. DOI: https://doi.org/10.1016/j.jddst.2024.106471

Deidda R, Orlandini S, Hubert P, Hubert C. Risk-based approach for method development in pharmaceutical quality control context: A critical review. Journal of pharmaceutical and biomedical analysis. 2018 Nov 30;161:110-21. DOI: https://doi.org/10.1016/j.jpba.2018.07.050

Aradhya G, Gowda S. Literature Review on Analytical Method Development and Validation of Alfuzosin Hydrochloride. Journal of Pharma Insights and Research. 2024 Aug 4;2(4):234-40. DOI: https://doi.org/10.69613/06st8337

Kulkarni R, Palled M. Stability Indicating UV Spectrophotometric Method for Loxoprofen Sodium: Method Development and Validation. International journal of pharmaceutical quality assurance. 2023 Dec 25;14(04):874–878. DOI: https://doi.org/10.25258/ijpqa.14.4.08

Hamza MY, Abd El Aziz ZR, Aly Kassem M, El-Nabarawi MA. Loxoprofen nanosponges: Formulation, characterization and ex-vivo study. International Journal of Applied Pharmaceutics. 2022 Mar 1;14(2):233-41. DOI: https://doi.org/10.22159/ijap.2022v14i2.43670

Zaman M, Adnan S, Saeed MA, Farooq M, Masood Z, Chishti SA, Qureshi J, Khan R. Formulation and in-vitro evaluation of sustained release matrix tablets of cellulose based hydrophilic and hydrophobic polymers loaded with loxoprofen sodium. Indo American J Pharma Res. 2013;3(9):7389-98.

El-Kafrawy DS, Abo-Gharam AH, Abdel-Khalek MM, Mahrous MS, Belal TS. Spectrophotometric estimation methods for loxoprofen sodium based on charge transfer complexation reactions. Research Journal of Pharmaceutical Biological and Chemical Sciences. 2018 Mar 1;9(2):669-81.

Zaman M, Sarfraz RM, Adnan S, Mahmood A, Hanif M, Qureshi J, Chaudhary MT, Akram MA, Bashir I. Development and in-vitro evaluation of once daily tablet dosage form of loxoprofen sodium. Tropical Journal of Pharmaceutical Research. 2015 Oct 9;14(9):1557-63. DOI: https://doi.org/10.4314/tjpr.v14i9.3

Nanthakumar R, Prabakaran V, Chitra K, Reddy CU. Estimation of loxoprofen sodium dihydrate in tablets by reverse phase high performance liquid chromatography. Arabian Journal of Chemistry. 2016 Sep 1;9:S632-6. DOI: https://doi.org/10.1016/j.arabjc.2011.07.010

Cho HY, Park CH, Lee YB. Direct and simultaneous analysis of loxoprofen and its diastereometric alcohol metabolites in human serum by on-line column switching liquid chromatography and its application to a pharmacokinetic study. Journal of Chromatography B. 2006 May 1;835(1-2):27-34. DOI: https://doi.org/10.1016/j.jchromb.2006.02.058

Farooq M, Shoaib MH, Yousuf RI, Siddiqui F, Hanif M, Naz S, Bashir L. Development and validation of liquid chromatographic method for quantitative determination of Loxoprofen in mobile phase and in human plasma. Pakistan Journal of Pharmaceutical Sciences. 2018 Nov 1;31(6):2629-33.

Shoaib MH, Ahmed FR, Yousuf RI, Siddiqui F, Saleem MT, Qazi F, Khan MZ, Irshad A, Bashir L, Naz S, Farooq M. SeDeM expert system with I-optimal mixture design for oral multiparticulate drug delivery: An encapsulated floating minitablets of loxoprofen Na and its in silico physiologically based pharmacokinetic modeling. Frontiers in Pharmacology. 2023 Mar 3;14:1066018. DOI: https://doi.org/10.3389/fphar.2023.1066018

Kashif M, Nisar-Ur-Rahman, Idrees HA, Aslam I, Iqbal SM, Mustafa R. HPL-UV detection method for quantification of loxoprofen in human plasma with liquid-liquid extraction technique: Application in pharmacokinetic study. LATIN AMERICAN JOURNAL OF PHARMACY. 2013 Jan 1;32(4):587-92.

Kulkarni RS, Palled MS. A rapid, sensitive and cost-effective RP-HPLC method for determination of loxoprofen sodium. Research Journal of Pharmacy and Technology. 2024;17(6):2889-94. DOI: https://doi.org/10.52711/0974-360X.2024.00453

Kim IW, Choo KS, Han TG, Kim KS, Chung SJ, Lee MH, Shim CK. Decreased oral bioavailability of loxoprofen at second administration in human subjects. International journal of clinical pharmacology and therapeutics. 2000 Jan 1;38(1):10-4. DOI: https://doi.org/10.5414/CPP38010

Cao S, Shi X, Han S, Fu Y, Liu X, Zhao P, Wang Z. Study of the stereospecificity in the biotransformation of the four isomers of loxoprofen sodium in rats by chiral HPLC. Journal of Separation Science. 2024 Jan;47(1):2300562. DOI: https://doi.org/10.1002/jssc.202300562

Venkatesan P, Janardhanan VS, Muralidharan C, Valliappan K. Improved HPLC Method with the Aid of Chemometric Strategy: Determination of Loxoprofen in Pharmaceutical Formulation. Acta Chimica Slovenica. 2012 Jun 1;59(2).

Eissa MS, Abd El-Sattar OI. Identification and structure elucidation of forced degradation products of the novel propionic acid derivative loxoprofen: development of stability-indicating chromatographic methods validated as per ICH guidelines. Journal of Chromatographic Science. 2017 Apr 1;55(4):417-28. DOI: https://doi.org/10.1093/chromsci/bmw196

Suzuki O, Watanabe K. Drugs and poisons in humans. Springer-Verlag Berlin Heidelberg; 2005.

Lee HW, Ji HY, Sohn DH, Kim SM, Lee YB, Lee HS. Liquid chromatography–tandem mass spectrometry method of loxoprofen in human plasma. Biomedical Chromatography. 2009 Jul;23(7):714-8. DOI: https://doi.org/10.1002/bmc.1175

Murakami T, Kawasaki T, Takemura A, Fukutsu N, Kishi N, Kusu F. Identification of degradation products in loxoprofen sodium adhesive tapes by liquid chromatography–mass spectrometry and dynamic pressurized liquid extraction–solid-phase extraction coupled to liquid chromatography–nuclear magnetic resonance spectroscopy. Journal of Chromatography A. 2008 Oct 24;1208(1-2):164-74. DOI: https://doi.org/10.1016/j.chroma.2008.08.076

Downloads

Published

16-07-2026

How to Cite

Doifode, S. S., & Kulkarni, R. (2026). Comprehensive review of Chromatographic, Hyphenated, and Spectrophotometric methods for the determination of Loxoprofen Sodium. Drug Analytical Research, 10(1), 13–21. https://doi.org/10.22456/dar.v10i1.154322

Issue

Section

REVIEW ARTICLES